Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individuals

Area of Science:

• Neurogenetics
• Immunology
• Endocrinology

Background:

• Multiple sclerosis (MS) has a significant genetic component beyond the HLA-DRB1*1501 allele.
• Evidence suggests a genetically influenced role for the neuroendocrine system in autoimmune diseases like MS.
• The hypothalamic-pituitary-adrenal (HPA) axis is a key neuroendocrine pathway implicated in stress response and autoimmunity.

Purpose of the Study:

• To investigate the association between variations in candidate hypothalamic-pituitary-adrenal (HPA) axis genes and susceptibility to multiple sclerosis (MS).
• To identify specific genetic variants within HPA axis genes that may influence MS risk.

Main Methods:

• A comprehensive analysis of 326 single nucleotide polymorphisms (SNPs) in eight candidate HPA axis genes was performed.
• A discovery dataset included 1343 MS cases and 1379 controls of European ancestry.
• Random Forests machine learning identified significant SNPs, followed by univariate analyses and a large meta-analysis for replication.

Main Results:

• Eight intronic SNPs within the corticotrophin-releasing hormone receptor 1 (CRHR1) gene locus were identified as important predictors of MS.
• Six CRHR1 variants were associated with a decreased risk of MS after correcting for multiple testing.
• A combined meta-analysis of nearly 4000 MS cases and over 8000 controls strongly implicated CRHR1 in MS pathogenesis, with rs242936 showing the most significant association.

Conclusions:

• The corticotrophin-releasing hormone receptor 1 (CRHR1) gene is significantly associated with multiple sclerosis (MS) susceptibility.
• Genetic variants within CRHR1, particularly on a specific haplotype, appear to confer a protective effect against MS.
• Further research into the role of HPA axis regulation and stress response in MS pathogenesis is warranted.